Melanoma during Ruxolitinib Treatment for Myelofibrosis

QR Code

Melanoma during Ruxolitinib Treatment for Myelofibrosis

Saved in:

Bibliographic Details
Main Authors:	Lingzhi Zhong, Houmin Li, Guangdong Wen
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2025-07-01
Series:	Acta Dermato-Venereologica
Subjects:	melanoma ruxolitinib myelofibrosis
Online Access:	https://medicaljournalssweden.se/actadv/article/view/44196
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Myelofibrosis: Treatment Options After Ruxolitinib Failure
by: Ruth Stuckey, et al.
Published: (2025-06-01)

Combination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis
by: M. S. Fominykh, et al.
Published: (2016-08-01)

Application of inhibitor JAK1 and JAK2 ruxolitinib as pre- and posttransplant therapy in patients with myelofibrosis
by: M. V. Barabanshchikova, et al.
Published: (2016-03-01)

Clinical and hematological factors predicting the effectiveness of ruxolitinib in primary and secondary myelofibrosis. Results of a prospective single-center study
by: O. Yu. Vinogradova, et al.
Published: (2024-09-01)

Possibilities of targeted therapy for myelofibrosis: Moscow experience
by: O. Yu. Vinogradova, et al.
Published: (2022-11-01)

Molecular markers as possible efficacy predictors of targeted therapy for myelofibrosis: single-center study
by: O. Yu. Vinogradova, et al.
Published: (2023-12-01)

Primary myelofibrosis: own experience and news from diagnostic and treatment
by: K. M. Abdulkadyrov, et al.
Published: (2015-06-01)

Primary and secondary myelofibrosis: ophthalmological manifestations at onset and during therapy
by: O. Yu. Vinogradova, et al.
Published: (2025-03-01)

Primary myelofibrosis L.
by: L. M. Meshcheryakova, et al.
Published: (2014-07-01)

Patients with primary myelofibrosis: treatment and quality of life
by: L. M. Meshcheryakova, et al.
Published: (2014-07-01)

Long-term results of splenectomy in primary myelofibrosis
by: L. M. Meshcheryakova, et al.
Published: (2014-07-01)

Evaluation of the Effects of Baricitinib and Ruxolitinib in Acute Respiratory Distress Syndrome (ARDS) Patients: A Meta-Analysis Study
by: Mehdi Nurmohammad Ahari, et al.
Published: (2025-04-01)

ADVANCED THERAPY IN PATIENTS WITH PRIMARY AND POSTPOLYCYTHEMIC MYELOFIBROSIS
by: A. N. Alekseeva, et al.
Published: (2017-07-01)

Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo
by: Weiran Li, MD, et al.
Published: (2025-10-01)

Difficulties in the differential diagnosis of erythema nodosum: Primary myelofibrosis as an etiological factor
by: D. I. Abdulganieva, et al.
Published: (2017-04-01)

CLINICO-PATHOMORPHOLOGICAL STUDY OF MYELOFIBROSIS IN MULTIPLE MYELOMA
by: Yu. A. Dyachkova, et al.
Published: (2016-02-01)

Generalized granulomatous inflammation caused by <i>Candida lusitaniae</i> in a patient with myelofibrosis
by: Yu. S. Korneva, et al.
Published: (2019-12-01)

Complicated course of portal hypertension on the background of primary myelofibrosis: a clinical case
by: V.B. Yagmur, et al.
Published: (2025-03-01)

Combination of multiple myeloma and chronic idiopathic myelofibrosis: a case report
by: N. A. Romanenko, et al.
Published: (2022-11-01)

PREDICTORS OF RESPONSE TO RUXOLITINIB THERAPY IN PATIENTS WITH MYELOFIBROSIS
by: Irina Turtanova, et al.
Published: (2025-07-01)

CLINICAL AND PATHOMORPHOLOGICAL EXAMINATION OF MYELOFIBROSIS IN CHRONIC MYELOID LEUKEMIA
by: T. Yu. Dolgikh, et al.
Published: (2016-02-01)

Hemostasis in patients with primary myelofibrosis treated with ruxolitinib
by: O. G. Golovina, et al.
Published: (2024-11-01)

Prognostic Implications of Red Blood Cell Distribution Width to Albumin Ratio in Myelofibrosis: A 10-Year Multicenter and Retrospective Study
by: Zeng T, et al.
Published: (2025-07-01)

Efficacy and safety of ruxolitinib in adult patients with refractory rheumatic disease-associated macrophage activation syndrome
by: Jingjing Li, et al.
Published: (2025-06-01)

Efficacy and safety of ruxolitinib combined with steroids for first-line treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: a single-center, real-world experience
by: Yan Yang, et al.
Published: (2025-07-01)

CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTOSIS AND PRIMARY MYELOFIBROSIS DEPENDING ON JAK2 AND CALR1 MUTATION STATUS
by: E. G. lisina, et al.
Published: (2017-10-01)

Actinium-225-PSMA-617 treatment in a patient with advanced prostate cancer causes secondary myelofibrosis: a case report and literature review
by: Ziye Wang, et al.
Published: (2025-07-01)

PATHOMORPHOLOGICAL ANALYSIS OF TREPANOBIOPTATES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOCYTIC LEUKEMIA: ASSESSMENT OF THE PROGNOSTIC VALUE OF MYELOFIBROSIS WHEN COMPARED WITH CLINICAL DATA
by: T. Y. Dolgikh, et al.
Published: (2019-02-01)

Cost-effectiveness of Ruxolitinib vs Best Available Therapy in the Treatment of Myelofibrosis in Spain
by: María Teresa Gómez-Casares, et al.
Published: (2017-11-01)

Acute graft versus host disease postliver transplant with mucocutaneous manifestations and pancytopenia: Remission with Janus kinase inhibitor
by: Roy Mendoza, BS, et al.
Published: (2025-08-01)

Melanoma maligno subungueal (lentiginoso acral)
by: Luis Fernando Arroyave Muñoz, et al.
Published: (1996-06-01)

Isolated Transpupillary Photodynamic Therapy in Local Treatment of Choroidal Melanoma
by: I. E. Panova, et al.
Published: (2025-03-01)

JUXTAPAPILLARY CHOROIDAL MELANOMA
by: A. S. Stoyukhina
Published: (2015-04-01)

Melanoma vulvar en pediatría. Reporte de caso
by: Jennifer A. Obregón-García, et al.
Published: (2025-07-01)

Melanoma maligno metastásico con primario cutáneo oculto
by: Luz Adriana Vásquez Ochoa, et al.
Published: (1999-11-01)

Melanoma maligno patrón epitelioide: melanoma animal
by: Mariam Rolón, et al.
Published: (2019-02-01)

CalR and MPL Driver Mutations and Their Role in the Diagnosis and Clinical Course of JAK2-Unmutated Chronic Myeloproliferative Neoplasm: Results from a Pilot Single-Center Study
by: Tarık Onur Tiryaki, et al.
Published: (2025-05-01)

Melanoma Vaccines: Comparing Novel Adjuvant Treatments in High-Risk Patients
by: Joseph C. Broderick, et al.
Published: (2025-06-01)

Clinical and morphological features and the assessment of survival in patients with iris melanoma
by: S. V. Saakyan, et al.
Published: (2024-03-01)

MICRORNA EXPRESSION PROFILE ALTERATIONS IN MELANOMA AND MELANOMA MICROENVIRONMENT
by: A. V. Komina, et al.
Published: (2016-02-01)